Performance and Safety Follow-up of Bioabsorbable Headless Inion CompressOnTM Screws in the Fixation of Bone Fractures in Ankle, Knee and Elbow of Pediatric and Adolescent Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 17
SponsorInion Oy

About this trial

The study in question is a post market clinical follow up (PMCF) study to follow up the safety and performance of bioabsorbable headless compression screw Inion CompressOn in fracture fixation of the ankle, knee and elbow of pediatric and adolescent patients. The study aims to recruit 80 patients who meet the acceptance criteria. The follow-up time for each study patient is 4 years. The study is a single center single group study which is conducted in Lighthouse Hospital at Turku University Hospital (TYKS) in Finland. The main focus of the study in terms of performance is to follow up the bone healing/ossification of operated areas. The main focus of the study in terms of safety is to evaluate the occurrence of adverse events and required revision surgeries that are or might be related to the study device.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Active infection

Patient conditions including limited blood supply (e.g. patients with severe circulatory disorder of the lower or upper limb)

Patient conditions including insufficient quality or quantity of bone (diagnosed osteoporosis, conditions causing secondary osteoporosis e.g. diabetes, rheumatism, eating disorder)

Patient conditions where patient cooperation cannot be guaranteed (alcohol use, drug abuse etc.)

Trial design

Design model

Single group

Treatments tested in this trial

  • Fracture fixation operation

    Device

    Fracture fixation operation in using bioabsorbable headless Inion CompressOn Screw/s according to instructions for use

Treatment groups

80 Participants
are divided into 1 treatment group
Group A: CompressOn groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Bone healing (ossification) of the fracture line(s)

X-ray evaluation of bone healing (ossification) of the fracture line(s)

Time frame
Change from operation to 4 years
2

Occurrence of device-related adverse events

Assessment of occurrence of adverse events (AE), that are or might be related to the study device such as non-union of bone, fixation failure, mechanical irritation and tissue reactions related to implant bioabsorption

Time frame
During 4-year follow-up
3

Occurrence of revision surgeries

Assessment of occurrence of revision surgeries related to study device

Time frame
During 4-year follow-up

Secondary outcomes

1

Subjective functionality of the operated limb (Visual Analogue Scale, VAS)

Evaluation of subjective pain of the operated area during follow-up. 10-cm (100-mm) horizontal line used to measure pain intensity, ranging from "no pain" (0) to "worst imaginable pain" (100 mm)

Time frame
Change from baseline to 4 years
2

Subjective functionality of the operated area (Lower Extremity Functional Scale, LEFS/Upper Extremity Functional Index, UEFI)

Evaluation of subjective functionality of the operated area follow-up. UEFI: The scores given to the 20 questions are added to give a highest possible score of 80. The lowest possible score is 0. A lower score indicates that the person is reporting increased difficulty with the activities as a result of their upper limb condition. LEFS: Contains 20 questions about a person's ability to perform everyday tasks. The maximum score is 80. The lower the score the greater the disability.

Time frame
Change from baseline to 4 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.